Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013299 · ClinicalTrials.gov registry record · Phase 2
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
A Phase 2 study of Diabetic Foot Ulcers, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 427
- Enrollment target
- 1
- Study location
NCT00013299: Completed Phase 2 study of Diabetic Foot Ulcers, sponsored by US Department of Veterans Affairs.
NCT00013299 is a Phase 2 study of Diabetic Foot Ulcers that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 427 participants, above the 199-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013299, a Phase 2 study of Diabetic Foot Ulcers, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 427 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized clinical trial to: (1) Determine the extent to which custom made study shoes will reduce the incidence of reulceration in diabetic individuals with prior history of foot ulcers, and (2) Estimate costs of ulcer prevention using these strategies.
Conditions Studied
Interventions
- DEVICE Prevention of Diabetic Ulcers
Study Locations (1)
Washington
- VAMC, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2000-10 |
| Est. Completion | 2001-04 |
| Phase | Phase 2 |
What the finished NCT00013299 record still lists
NCT00013299 is an interventional study that assigns participants to a tested intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap, above the 199-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (115% higher).
The record links to 1 condition, with Diabetic Foot Ulcers appearing as the primary indexed condition, and to 1 intervention - of which Prevention of Diabetic Ulcers is the first listed.
NCT00013299 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00013299 about?
NCT00013299 is a clinical study titled "Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3". This is a randomized clinical trial to: (1) Determine the extent to which custom made study shoes will reduce the incidence of reulceration in diabetic individuals with prior history of foot ulcers, and (2) Estimate costs of ulcer prevention using these strategies.
What is the current status of trial NCT00013299?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 427 participants. The study started on 2000-10. Estimated completion is 2001-04.
What conditions does trial NCT00013299 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers.
What interventions are being tested in trial NCT00013299?
The interventions under investigation include: Prevention of Diabetic Ulcers (DEVICE).
Who is sponsoring clinical trial NCT00013299?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013299 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00013299's enrollment target sits among peer trials
427 3rd of 12 higher than 10 of 12 other Diabetic Foot Ulcers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
COMPLETED · Phase 2
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
COMPLETED
-
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
COMPLETED · Phase 1
-
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia